Search
for
Sort by
Research 841–870 of 1000+
- Testosterone Pellets in Women: Revisiting Safety and Clinical Outcomes
- Prostate Specific Antigen as Predictive Factor for Androgenemia in Women
- Steroid sulfatase inhibitors
- Corticotropin releasing factor-1 receptor antagonism associated with favorable outcomes of male reproductive health biochemical parameters
- Androgenetic alopecia
- Androgenetic Alopecia: Overview
- Antiaging effects of equol: A unique antiandrogenic isoflavone metabolite and its influence in stimulating collagen deposition in human dermal monolayer fibroblasts
- Visual Vignette
- Early Baldness in Males and Hormonal Changes
- Early Baldness in Males and Hormonal Changes
- Haarverlies volgens het vrouwelijk patroon:Een folder voor uw patiënten
- Anti-androgen hormonal therapy for cancer and other diseases
- Metformin use in women with polycystic ovary syndrome (PCOS): Opportunities, benefits, and clinical challenges.
- Pathways to inflammation: acne pathophysiology
- Physiology and Medical Treatments for Alopecia
- Personalized Medicine in the Field of Inflammatory Skin Disorders
- Platelet-rich plasma therapy in the treatment of androgenic alopecia – review
- Fertility and Sterility Vol 101 No 4, April 2014
- Hyperandrogenemia in an ethnically heterogeneous cohort of Midwestern United States diabetic gestations
- Basics of androgen synthesis and action
- Prescribing testosterone and DHEA: The role of androgens in women
- Alopecia: unapproved treatments or indications
- The role of dexamethasone in mediating the contradictory effects of Wnt antagonists SFRP2 and SFRP3 on human hair follicle growth
- 498 Innate immunity activation of sebocyte cells by living bacteria. Evidence of a potential immunosuppressive effect of DHT
- Foreword
- <i>Polycystic Ovary Syndrome in Adolescence</i>
- 6 Current concepts of polycystic ovary syndrome
- Association between ovarian volume and serum insulin levels in ovulatory patients with idiopathic hirsutism
- Adrenal Cortex Tumors and Hyperplasias
- 5α-reductase Inhibitors: Finasteride and Dutasteride in Feminising Therapy